Enzyme-Linked Immunosorbent Assay (ELISA) Testing Market Size, Share, Growth, Trends, and Forecast 2032

Enzyme-linked immunosorbent assay (ELISA) testing Market

Enzyme-linked immunosorbent assay (ELISA) testing Market by Test type (Sandwich ELISA, Indirect ELISA, Multiple and portable ELISA, and Competitive ELISA) By Application (Immunology, Inflammation, Infectious diseases, Cancer, Protein quantification, and others): Global Industry Perspective, Comprehensive Analysis and Forecast, 2024 - 2032-

Category: Pharmaceutical Report Format : PDF Pages: 140 Report Code: ZMR-1978 Published Date: Nov-2024 Status : Published
Market Size in 2023 Market Forecast in 2032 CAGR (in %) Base Year
USD 2.59 Billion USD 5.75 Billion 8.3% 2023

Enzyme-linked immunosorbent assay (ELISA) testing Market

Request For Customization Request Free Sample Buy Now

Table Of Content

  • Chapter No. 1 Introduction
    • 1.1. Report Description
      • 1.1.1. Purpose of the Report
      • 1.1.2. USP & Key Offerings
    • 1.2. Key Benefits for Stakehulders
    • 1.3. Target Audience
    • 1.4. Report Scope
  • Chapter No. 2 Executive Summary
    • 2.1. Key Findings
      • 2.1.1. Top Investment Pockets
        • 2.1.1.1. Market Attractiveness Analysis, By Test type
        • 2.1.1.2. Market Attractiveness Analysis, By Application
        • 2.1.1.3. Market Attractiveness Analysis, By Region
    • 2.2. Market Snapshot
    • 2.3. Global Enzyme-linked immunosorbent assay (ELISA) testing Market, 2016 – 2028 (USD Million)
    • 2.4. Insights from Primary Respondents
  • Chapter No. 3 COVID 19 Impact Analysis
    • 3.1. Impact Assessment of COVID-19 Pandemic, By Region
      • 3.1.1. North America
      • 3.1.2. Europe
      • 3.1.3. Asia Pacific
      • 3.1.4. Latin America
      • 3.1.5. The Middle-East and Africa
    • 3.2. Quarterly Market Revenue and Forecast by Region 2020 & 2021
    • 3.3. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million)
    • 3.4. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million)
    • 3.5. Key Strategies Undertaken by Companies to Tackle COVID-19
      • 3.5.1. Company Quarterly Revenue Analysis, 2019 & 2020
    • 3.6. Short Term Dynamics
    • 3.7. Long Term Dynamics
  • Chapter No. 4 Enzyme-linked immunosorbent assay (ELISA) testing Market – Test type Segment Analysis
    • 4.1. Overview
      • 4.1.1. Market Revenue Share, By Test type, 2020 & 2028
    • 4.2. Soil
      • 4.2.1. Market Size and Forecast, By Region (USD Million)
      • 4.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 4.3. Indirect ELISA
      • 4.3.1. Market Size and Forecast, By Region (USD Million)
      • 4.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 4.3.3. Key Market Trends, Growth Factors, & Opportunities
  • Chapter No. 5 Enzyme-linked immunosorbent assay (ELISA) testing Market – Application Segment Analysis
    • 5.1. Overview
      • 5.1.1. Market Revenue Share, By Application, 2020 & 2028
    • 5.2. Immunulogy
      • 5.2.1. Market Size and Forecast, By Region (USD Million)
      • 5.2.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.2.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.3. Inflammation
      • 5.3.1. Market Size and Forecast, By Region (USD Million)
      • 5.3.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.3.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.4. Infectious diseases
      • 5.4.1. Market Size and Forecast, By Region (USD Million)
      • 5.4.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.4.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.5. Cancer
      • 5.5.1. Market Size and Forecast, By Region (USD Million)
      • 5.5.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.5.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.6. Protein quantification
      • 5.6.1. Market Size and Forecast, By Region (USD Million)
      • 5.6.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.6.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.7. Others
      • 5.7.1. Market Size and Forecast, By Region (USD Million)
      • 5.7.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.7.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.8. Construction and Land Development
      • 5.8.1. Market Size and Forecast, By Region (USD Million)
      • 5.8.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.8.3. Key Market Trends, Growth Factors, & Opportunities
    • 5.9. Others
      • 5.9.1. Market Size and Forecast, By Region (USD Million)
      • 5.9.2. Comparative Revenue Analysis, By Country, 2020 & 2028
      • 5.9.3. Key Market Trends, Growth Factors, & Opportunities
    • 6.1. Overview
      • 6.1.1. Global Market Revenue Share, By Region, 2020 & 2028
      • 6.1.2. Global Market Revenue, By Region, 2016 – 2028 (USD Million)
    • 6.2. North America
      • 6.2.1. North America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.2.2. North America Market Revenue, By Test type, 2016 – 2028
      • 6.2.3. North America Market Revenue, By Application, 2016 – 2028
      • 6.2.5. U.S.
        • 6.2.5.1. U.S. Market Revenue, By Test type, 2016 – 2028
        • 6.2.5.2. U.S. Market Revenue, By Application, 2016 – 2028
      • 6.2.6. Canada
        • 6.2.6.1. Canada Market Revenue, By Test type, 2016 – 2028
        • 6.2.6.2. Canada Market Revenue, By Application, 2016 – 2028
      • 6.2.7. Mexico
        • 6.2.7.1. Mexico Market Revenue, By Test type, 2016 – 2028
        • 6.2.7.2. Mexico Market Revenue, By Application, 2016 – 2028
    • 6.3. Europe
      • 6.3.1. Europe Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.3.2. Europe Market Revenue, By Test type, 2016 – 2028
      • 6.3.3. Europe Market Revenue, By Application, 2016 – 2028
      • 6.3.5. Germany
        • 6.3.5.1. Germany Market Revenue, By Test type, 2016 – 2028
        • 6.3.5.2. Germany Market Revenue, By Application, 2016 – 2028
      • 6.3.6. France
        • 6.3.6.1. France Market Revenue, By Test type, 2016 – 2028
        • 6.3.6.2. France Market Revenue, By Application, 2016 – 2028
      • 6.3.7. U.K.
        • 6.3.7.1. U.K. Market Revenue, By Test type, 2016 – 2028
        • 6.3.7.2. U.K. Market Revenue, By Application, 2016 – 2028
      • 6.3.8. Italy
        • 6.3.8.1. Italy Market Revenue, By Test type, 2016 – 2028
        • 6.3.8.2. Italy Market Revenue, By Application, 2016 – 2028
      • 6.3.9. Spain
        • 6.3.9.1. Spain Market Revenue, By Test type, 2016 – 2028
        • 6.3.9.2. Spain Market Revenue, By Application, 2016 – 2028
      • 6.3.10. Rest of Europe
        • 6.3.10.1. Rest of Europe Market Revenue, By Test type, 2016 – 2028
        • 6.3.10.2. Rest of Europe Market Revenue, By Application, 2016 – 2028
    • 6.4. Asia Pacific
      • 6.4.1. Asia Pacific Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.4.2. Asia Pacific Market Revenue, By Test type, 2016 – 2028
      • 6.4.3. Asia Pacific Market Revenue, By Application, 2016 – 2028
      • 6.4.5. China
        • 6.4.5.1. China Market Revenue, By Test type, 2016 – 2028
        • 6.4.5.2. China Market Revenue, By Application, 2016 – 2028
      • 6.4.6. Japan
        • 6.4.6.1. Japan Market Revenue, By Test type, 2016 – 2028
        • 6.4.6.2. Japan Market Revenue, By Application, 2016 – 2028
      • 6.4.7. India
        • 6.4.7.1. India Market Revenue, By Test type, 2016 – 2028
        • 6.4.7.2. India Market Revenue, By Application, 2016 – 2028
      • 6.4.8. South Korea
        • 6.4.8.1. South Korea Market Revenue, By Test type, 2016 – 2028
        • 6.4.8.2. South Korea Market Revenue, By Application, 2016 – 2028
      • 6.4.9. South-East Asia
        • 6.4.9.1. South-East Asia Market Revenue, By Test type, 2016 – 2028
        • 6.4.9.2. South-East Asia Market Revenue, By Application, 2016 – 2028
      • 6.4.10. Rest of Asia Pacific
        • 6.4.10.1. Rest of Asia Pacific Market Revenue, By Test type, 2016 – 2028
        • 6.4.10.2. Rest of Asia Pacific Market Revenue, By Application, 2016 – 2028
    • 6.5. Latin America
      • 6.5.1. Latin America Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.5.2. Latin America Market Revenue, By Test type, 2016 – 2028
      • 6.5.3. Latin America Market Revenue, By Application, 2016 – 2028
      • 6.5.5. Brazil
        • 6.5.5.1. Brazil Market Revenue, By Test type, 2016 – 2028
        • 6.5.5.2. Brazil Market Revenue, By Application, 2016 – 2028
      • 6.5.6. Argentina
        • 6.5.6.1. Argentina Market Revenue, By Test type, 2016 – 2028
        • 6.5.6.2. Argentina Market Revenue, By Application, 2016 – 2028
      • 6.5.7. Rest of Latin America
        • 6.5.7.1. Rest of Latin America Market Revenue, By Test type, 2016 – 2028
        • 6.5.7.2. Rest of Latin America Market Revenue, By Application, 2016 – 2028
    • 6.6. The Middle-East and Africa
      • 6.6.1. The Middle-East and Africa Market Revenue, By Country, 2016 – 2028 (USD Million)
      • 6.6.2. The Middle-East and Africa Market Revenue, By Test type, 2016 – 2028
      • 6.6.3. The Middle-East and Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.5. GCC Countries
        • 6.6.5.1. GCC Countries Market Revenue, By Test type, 2016 – 2028
        • 6.6.5.2. GCC Countries Market Revenue, By Application, 2016 – 2028
      • 6.6.6. South Africa
        • 6.6.6.1. South Africa Market Revenue, By Test type, 2016 – 2028
        • 6.6.6.2. South Africa Market Revenue, By Application, 2016 – 2028
      • 6.6.7. Rest of Middle-East Africa
        • 6.6.7.1. Rest of Middle-East Africa Market Revenue, By Test type, 2016 – 2028
        • 6.6.7.2. Rest of Middle-East Africa Market Revenue, By Application, 2016 – 2028
  • Chapter No. 7: Enzyme-linked immunosorbent assay (ELISA) testing Market – Industry Analysis
    • 7.1. Introduction
    • 7.2. Market Drivers
      • 7.2.1. Driving Factor 1 Analysis
      • 7.2.2. Driving Factor 2 Analysis
    • 7.3. Market Restraints
      • 7.3.1. Restraining Factor Analysis
    • 7.4. Market Opportunities
      • 7.4.1. Market Opportunity Analysis
    • 7.5. Porter’s Five Forces Analysis
    • 7.6. PEST Analysis
    • 7.7. Regulatory Landscape
    • 7.8. Test type Landscape
    • 7.9. Regional Market Trends
      • 7.9.1. North America
      • 7.9.2. Europe
      • 7.9.3. Asia Pacific
      • 7.9.4. Latin America
      • 7.9.5. The Middle-East and Africa
    • 7.10. Pricing Analysis
    • 7.11. Value Chain Analysis
    • 7.12. Downstream Buyers
    • 7.13. Distributors/Traders List
  • Chapter No. 8: Competitive Landscape
    • 8.1. Company Market Share Analysis – 2019
      • 8.1.1. Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Company Market Share, 2019
      • 8.1.2. Global Enzyme-linked immunosorbent assay (ELISA) testing Market, Company Market Revenue, 2016 – 2019 (USD Million)
      • 8.1.3. Global Enzyme-linked immunosorbent assay (ELISA) testing Market, Company Y-o-Y Growth, 2017 – 2019 (%)
      • 8.1.4. Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Radar Determinant Chart, 2019
    • 8.2. Strategic Developments
      • 8.2.1. Acquisitions & Mergers
      • 8.2.2. New Product Launch
      • 8.2.3. Regional Expansion
    • 8.3. Company Strategic Developments – Heat Map Analysis
  • Chapter No. 9: Company Profiles
    • 9.1. GEO Inc
      • 9.1.1. Company Overview
      • 9.1.2. Key Executives
      • 9.1.3. Product Portfolio
      • 9.1.4. Financial Overview
      • 9.1.5. Operating Business Segments
      • 9.1.6. Business Performance
      • 9.1.7. Recent Developments
    • 9.2. Enzyme-linked immunosorbent assay (ELISA) testing Resources Pty Ltd
    • 9.3. Gulder Associates Corporation
    • 9.4. Clean Harbors
    • 9.5. Entact LLC
    • 9.6. Brisea Group, Inc
    • 9.7. Environmental and Marine Engineering NV (Belgium)
    • 9.8. Dredging
    • 9.9. Newterra Ltd
    • 9.10. Terra Systems, Inc.
  • Chapter No. 10: Marketing Strategy Analysis
    • 10.1. Marketing Channel
    • 10.2. Direct Marketing
    • 10.3. Indirect Marketing
    • 10.4. Marketing Channel Development Trends
    • 10.5. Economic/Pulitical Environmental Change
  • Chapter No. 11: Research Methodology
    • 11.1. Research Methodology
    • 11.2. Phase I - Secondary Research
    • 11.3. Phase II - Data Modeling
      • 11.3.1. Company Share Analysis Model
      • 11.3.2. Revenue Based Modeling
    • 11.4. Phase III - Primary Research
    • 11.5. Research Limitations
      • 11.5.1. Assumptions

Table Of Figures

List of Figures 

FIG NO. 1. Market Attractiveness Analysis, By Test type
FIG NO. 2. Market Attractiveness Analysis, By Application
FIG NO. 3. Market Attractiveness Analysis, By Region
FIG NO. 4. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, 2016 – 2028 (USD Million)
FIG NO. 5. Impact of COVID-19 Pandemic in North America Countries
FIG NO. 6. Market Revenue Share, By Test type, 2020 & 2028 
FIG NO. 7. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Soil, Revenue (USD Million) 2016 – 2028
FIG NO. 8. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Soil, By Country, 2020 & 2028
FIG NO. 9. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Indirect ELISA, Revenue (USD Million) 2016 – 2028
FIG NO. 10. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Indirect ELISA, By Country, 2020 & 2028
FIG NO. 11. Market Revenue Share, By Application, 2020 & 2028
FIG NO. 12. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Immunology, Revenue (USD Million) 2016 – 2028
FIG NO. 13. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Immunology, By Country, 2020 & 2028 
FIG NO. 14. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Inflammation, Revenue (USD Million) 2016 – 2028
FIG NO. 15. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Inflammation, By Country, 2020 & 2028
FIG NO. 16. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Infectious diseases, Revenue (USD Million) 2016 – 2028 
FIG NO. 17. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Infectious diseases, By Country, 2020 & 2028
FIG NO. 18. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Cancer, Revenue (USD Million) 2016 – 2028
FIG NO. 19. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Cancer, By Country, 2020 & 2028
FIG NO. 20. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Protein quantification, Revenue (USD Million) 2016 – 2028
FIG NO. 21. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Protein quantification, By Country, 2020 & 2028
FIG NO. 22. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 23. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Others, By Country, 2020 & 2028
FIG NO. 24. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Construction and Land Development, Revenue (USD Million) 2016 – 2028
FIG NO. 25. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Construction and Land Development, By Country, 2020 & 2028
FIG NO.26. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Others, Revenue (USD Million) 2016 – 2028
FIG NO. 27. Comparative Revenue Analysis of Enzyme-linked immunosorbent assay (ELISA) testing Market for Construction, By Country, 2020 & 2028
FIG NO. 28. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue Share, By Region, 2020 & 2028
FIG NO. 29. North America Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, 2016 - 2028 (USD Million)
FIG NO. 30. Porter’s Five Forces Analysis for Global Enzyme-linked immunosorbent assay (ELISA) testing Market
FIG NO. 31. PEST Analysis for Global Enzyme-linked immunosorbent assay (ELISA) testing Market
FIG NO. 32. Pricing Analysis for Global Enzyme-linked immunosorbent assay (ELISA) testing Market
FIG NO. 33. Value Chain Analysis for Global Enzyme-linked immunosorbent assay (ELISA) testing Market
FIG NO. 34. Company Share Analysis, 2019
FIG NO. 35. Radar Determinant Chart, 2019
FIG NO. 36. Company Strategic Developments – Heat Map Analysis
FIG NO. 37. GEO Inc Business Segment Revenue Share, 2020 (%)
FIG NO. 38. GEO Inc Geographical Segment Revenue Share, 2020 (%)
FIG NO. 39. Market Channels
FIG NO. 40. Marketing Channel Development Trend
FIG NO. 41. Growth in World Gross Product, 2008-2018
FIG NO. 42. Research Methodology – Detailed View
FIG NO. 43. Research Methodology
 


Table Of Tables

List of Tables 

TABLE NO. 1. Global Enzyme-linked immunosorbent assay (ELISA) testing Market: Snapshot
TABLE NO. 2. Quarterly Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue by Region, 2020
TABLE NO. 3. Quarterly Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue Forecast by Region, 2021
TABLE NO. 4. Pre COVID-19 Market Revenue, By Region, 2016-2019 (USD Million) 
TABLE NO. 5. Post COVID-19 Market Revenue, By Region, 2020-2028 (USD Million) 
TABLE NO. 6. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Soil, by Region, 2016 – 2028 (USD Million)
TABLE NO. 7. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Indirect ELISA, by Region, 2016 – 2028 (USD Million)
TABLE NO. 8: Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Immunology, by Region, 2016 – 2028 (USD Million)
TABLE NO. 9: Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Inflammation, by Region, 2016 – 2028 (USD Million)
TABLE NO. 10. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Infectious diseases, by Region, 2016 – 2028 (USD Million)
TABLE NO. 11. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Cancer, by Region, 2016 – 2028 (USD Million)
TABLE NO. 12. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Protein quantification, by Region, 2016 – 2028 (USD Million)
TABLE NO. 13. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 14. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Construction and Land Development, by Region, 2016 – 2028 (USD Million)
TABLE NO. 15. Global Enzyme-linked immunosorbent assay (ELISA) testing Market for Others, by Region, 2016 – 2028 (USD Million)
TABLE NO. 16. Global Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Region, 2016 – 2028 (USD Million)
TABLE NO. 17. North America Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Country, 2016 – 2028 (USD Million)
TABLE NO. 18. North America Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Test type, 2016 – 2028 (USD Million)
TABLE NO. 19. North America Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 20. U.S. Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Test type, 2016 – 2028 (USD Million)
TABLE NO. 21. U.S. Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 22. Canada Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Test type, 2016 – 2028 (USD Million)
TABLE NO. 23. Canada Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 24. Mexico Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Test type, 2016 – 2028 (USD Million)
TABLE NO. 25. Mexico Enzyme-linked immunosorbent assay (ELISA) testing Market Revenue, By Application, 2016 – 2028 (USD Million)
TABLE NO. 26. Drivers for the Enzyme-linked immunosorbent assay (ELISA) testing Market: Impact Analysis
TABLE NO. 27. Restraints for the Enzyme-linked immunosorbent assay (ELISA) testing Market: Impact Analysis
TABLE NO. 28. Major Buyers of Enzyme-linked immunosorbent assay (ELISA) testing
TABLE NO. 29. Distributors/Traders List of Enzyme-linked immunosorbent assay (ELISA) testing
TABLE NO. 30. Global Enzyme-linked immunosorbent assay (ELISA) testing Market, Company Market Revenue, 2016 – 2019 (USD Million)
TABLE NO. 31: Global Enzyme-linked immunosorbent assay (ELISA) testing Market, Company Y-o-Y Growth, 2017 – 2019 (USD Million)   
 

Methodology

FrequentlyAsked Questions

The global Enzyme-linked immunosorbent assay (ELISA) testing Market was valued at USD 2.59 Billion in 2023.

The global Enzyme-linked immunosorbent assay (ELISA) testing Market is expected to reach USD 5.75 Billion by 2032, growing at a CAGR of 8.3% between 2024 to 2032.

Some of the key factors driving the global Enzyme-linked immunosorbent assay (ELISA) testing Market growth are increasing research and development on biomarkers and monoclonal antibodies (mABs) coupled along with continued growth in drug discovery market.  

North America has been leading the worldwide Enzyme-linked immunosorbent assay (ELISA) testing market and is anticipated to continue on the dominant position in the years to come, states the market study.

Some of the major players of global Enzyme-linked immunosorbent assay (ELISA) testing market includes Thermo Fisher Scientific. Inc., American Laboratory Products Company (ALPCO), BD Biosciences, Bio-Rad Laboratories, Inc., BioMérieux, Ortho-Clinical Diagnostics, Inc., R & D Systems Inc. and ZEUS Scientific, Inc. among others.

Choose License Type

  • zion payment modes

List of Contents

Enzyme-linked Immunosorbent Assay (ELISA) Testing Market InsightsEnzyme-linked Immunosorbent Assay (ELISA) Testing OverviewEnzyme-linked Immunosorbent Assay (ELISA) Testing COVID-19 Impact AnalysisEnzyme-linked Immunosorbent Assay (ELISA) Testing Growth Factors Report ScopeSegment Analysis Preview Enzyme-linked Immunosorbent Assay (ELISA) Testing Market:Competitive LandscapeThe global Market is segmented as follows:By Test type By Applications By Region

RelatedNews

HappyClients

Office Address

Contact Us

Zion Market Research
Tel: +1 (302) 444-0166
USA/Canada Toll Free No.+1 (855) 465-4651

Asia Pacific Office

3rd Floor, Mrunal Paradise, Opp Maharaja Hotel, Pimple Gurav, Pune 411061, Maharashtra, India
Phone No +91 7768 006 007, +91 7768 006 008

Contact #

US OFFICE NO +1 (302) 444-0166
US/CAN TOLL FREE +1 (855) 465-4651
Email: sales@zionmarketresearch.com

We Are On Social

twitter

Industry Press Release

We Accept

We have secured system to process your transaction.

  • payment methods

How it Works?

Our Company

Business Hours

Our support available to help you 24 hours a day, five days a week.

Monday - Friday: 9AM - 6PM

Saturday - Sunday: Closed